US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist
  • 0.264
  • -0.005-2.01%
Close Nov 12 16:00 ET
  • 0.271
  • +0.007+2.81%
Post 19:52 ET
3.65MMarket Cap-129P/E (TTM)

Silexion Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.05%1.39M
54.70%1.25M
21.27%4.68M
1.41M
808K
3.86M
Selling and administrative expenses
270.91%612K
150.89%281K
60.83%928K
--165K
--112K
--577K
-General and administrative expense
270.91%612K
150.89%281K
60.83%928K
--165K
--112K
--577K
Research and development costs
-37.98%766K
41.12%961K
14.94%3.71M
--1.24M
--681K
--3.23M
Depreciation amortization depletion
-50.00%7K
-46.67%8K
-21.05%45K
--14K
--15K
--57K
-Depreciation and amortization
-50.00%7K
-46.67%8K
-21.05%45K
--14K
--15K
--57K
Operating profit
2.05%-1.39M
-54.70%-1.25M
-21.27%-4.68M
-1.41M
-808K
-3.86M
Net non-operating interest income expense
-87.88%4K
-50.00%19K
396.55%144K
33K
38K
29K
Non-operating interest income
-84.62%6K
-51.28%19K
34.21%153K
--39K
--39K
--114K
Non-operating interest expense
-33.33%2K
----
----
--3K
----
----
Total other finance cost
----
----
-89.41%9K
--3K
--1K
--85K
Other net income (expense)
78.14%-106K
-605.41%-187K
-246.87%-539K
-485K
37K
367K
Gain on sale of security
78.14%-106K
-605.41%-187K
-246.87%-539K
---485K
--37K
--367K
Income before tax
20.31%-1.49M
-93.45%-1.42M
-46.54%-5.08M
-1.87M
-733K
-3.46M
Income tax
-80.00%2K
-50.00%5K
33.33%32K
10K
10K
24K
Net income
20.63%-1.49M
-91.52%-1.42M
-46.44%-5.11M
-1.88M
-743K
-3.49M
Net income continuous Operations
20.63%-1.49M
-91.52%-1.42M
-46.44%-5.11M
---1.88M
---743K
---3.49M
Minority interest income
92.38%-17K
-261.29%-50K
39.19%-166K
-223K
31K
-273K
Net income attributable to the parent company
10.95%-1.47M
-77.39%-1.37M
-53.72%-4.94M
-1.65M
-774K
-3.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.95%-1.47M
-77.39%-1.37M
-53.72%-4.94M
-1.65M
-774K
-3.22M
Basic earnings per share
10.95%-0.1806
-77.39%-0.1684
-53.72%-0.6063
-0.2028
-0.095
-0.3944
Diluted earnings per share
10.95%-0.1806
-77.39%-0.1684
-53.72%-0.6063
-0.2028
-0.095
-0.3944
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.05%1.39M54.70%1.25M21.27%4.68M1.41M808K3.86M
Selling and administrative expenses 270.91%612K150.89%281K60.83%928K--165K--112K--577K
-General and administrative expense 270.91%612K150.89%281K60.83%928K--165K--112K--577K
Research and development costs -37.98%766K41.12%961K14.94%3.71M--1.24M--681K--3.23M
Depreciation amortization depletion -50.00%7K-46.67%8K-21.05%45K--14K--15K--57K
-Depreciation and amortization -50.00%7K-46.67%8K-21.05%45K--14K--15K--57K
Operating profit 2.05%-1.39M-54.70%-1.25M-21.27%-4.68M-1.41M-808K-3.86M
Net non-operating interest income expense -87.88%4K-50.00%19K396.55%144K33K38K29K
Non-operating interest income -84.62%6K-51.28%19K34.21%153K--39K--39K--114K
Non-operating interest expense -33.33%2K----------3K--------
Total other finance cost ---------89.41%9K--3K--1K--85K
Other net income (expense) 78.14%-106K-605.41%-187K-246.87%-539K-485K37K367K
Gain on sale of security 78.14%-106K-605.41%-187K-246.87%-539K---485K--37K--367K
Income before tax 20.31%-1.49M-93.45%-1.42M-46.54%-5.08M-1.87M-733K-3.46M
Income tax -80.00%2K-50.00%5K33.33%32K10K10K24K
Net income 20.63%-1.49M-91.52%-1.42M-46.44%-5.11M-1.88M-743K-3.49M
Net income continuous Operations 20.63%-1.49M-91.52%-1.42M-46.44%-5.11M---1.88M---743K---3.49M
Minority interest income 92.38%-17K-261.29%-50K39.19%-166K-223K31K-273K
Net income attributable to the parent company 10.95%-1.47M-77.39%-1.37M-53.72%-4.94M-1.65M-774K-3.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.95%-1.47M-77.39%-1.37M-53.72%-4.94M-1.65M-774K-3.22M
Basic earnings per share 10.95%-0.1806-77.39%-0.1684-53.72%-0.6063-0.2028-0.095-0.3944
Diluted earnings per share 10.95%-0.1806-77.39%-0.1684-53.72%-0.6063-0.2028-0.095-0.3944
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data